Study of Oral Lucitanib (E-3810), a Dual VEGFR-FGFR Tyrosine Kinase Inhibitor, in Patients With Solid Tumors
Clinical trial NCT01283945 · COMPLETED
Trial details
- NCT number
- NCT01283945
- Sponsor
- Institut de Recherches Internationales Servier
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2016-09-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.